文献速递呼吸道感染

吸入性社区获得性肺炎的危险因素、微生物学与经验性抗生素使用

Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia.
PubMed 文献 · Chest · 2020-07-17

该研究为GLIMP国际多中心点患病率研究的二次分析,纳入2606例住院社区获得性肺炎(CAP)成人患者,其中193例(7.4%)为吸入性社区获得性肺炎(ACAP)。ACAP与CAP伴吸入危险因素(AspRF+)患者的厌氧菌检出率与无吸入危险因素者相似,但重度ACAP患者革兰阴性菌比例更高,且各亚组中多数患者接受了抗厌氧菌覆盖治疗。

要点

  • ACAP独立相关因素包括男性、卧床、低体重、养老院居住及卒中、痴呆、精神疾病和肠内管饲史。
  • ACAP、CAP/AspRF+与CAP/AspRF-三组厌氧菌检出率相似(0.0% vs 1.03% vs 1.64%)。
  • 重度ACAP患者革兰阴性菌比例高于重度CAP/AspRF+和CAP/AspRF-患者。

核心结论

  • 住院ACAP或CAP/AspRF+患者与无吸入危险因素患者的厌氧菌菌群相似。
  • 重度ACAP患者中革兰阴性菌更常见。
  • 尽管各组微生物学菌群相似,大部分CAP患者仍接受了抗厌氧菌抗生素覆盖。

研究设计与样本

  • GLIMP国际多中心点患病率研究的二次分析。
  • 纳入2606例住院CAP成人患者,其中193例(7.4%)为ACAP。
  • 患者分为ACAP、CAP/AspRF+和CAP/AspRF-三组,并进一步按重度与非重度CAP分层。

主要发现

  • ACAP独立相关因素为男性、卧床、低体重、养老院居住、卒中史、痴呆、精神疾病和肠内管饲。
  • 非ACAP患者中1709例(70.8%)为CAP/AspRF+,704例(29.2%)为CAP/AspRF-。
  • 厌氧菌检出率在CAP/AspRF-、CAP/AspRF+和ACAP中分别为0.0%、1.03%和1.64%。
  • 重度ACAP患者总革兰阴性菌率为64.3%,高于重度CAP/AspRF+的44.3%和重度CAP/AspRF-的33.3%(P = .021)。
  • 重度ACAP患者总革兰阳性菌率为7.1%,低于重度CAP/AspRF+的38.1%和重度CAP/AspRF-的50.0%(P < .001)。

关键数值与推荐

  • ACAP诊断依据为存在吸入危险因素,占住院CAP患者的7.4%(193/2606)。
  • 所有组中超过50%的患者接受了特异性或广谱抗厌氧菌覆盖抗生素。

临床怎么用

  • 对住院CAP患者应评估吸入危险因素(卧床、管饲、卒中、痴呆等)以识别ACAP。
  • 重度ACAP经验性抗菌治疗需考虑革兰阴性菌覆盖。
  • 无吸入危险因素者厌氧菌检出率低,抗厌氧菌覆盖应结合病情个体化权衡。

局限性

  • 为点患病率研究的二次分析,可能存在选择偏倚。
  • 微生物学结果依赖各中心培养方法,厌氧菌检出率低可能受技术限制。
  • 未报告抗厌氧菌治疗与临床结局的关联分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspiration community-acquired pneumonia (ACAP) and community-acquired pneumonia (CAP) in patients with aspiration risk factors (AspRFs) are infections associated with anaerobes, but limited evidence suggests their pathogenic role. RESEARCH QUESTION: What are the aspiration risk factors, microbiology patterns, and empiric anti-anaerobic use in patients hospitalized with CAP? STUDY DESIGN AND METHODS: This is a secondary analysis of GLIMP, an international, multicenter, point-prevalence study of adults hospitalized with CAP. Patients were stratified into three groups: (1) ACAP, (2) CAP/AspRF+ (CAP with AspRF), and (3) CAP/AspRF- (CAP without AspRF). Data on demographics, comorbidities, microbiological results, and anti-anaerobic antibiotics were analyzed in all groups. Patients were further stratified in severe and nonsevere CAP groups. RESULTS: We enrolled 2,606 patients with CAP, of which 193 (7.4%) had ACAP. Risk factors independently associated with ACAP were male, bedridden, underweight, a nursing home resident, and having a history of stroke, dementia, mental illness, and enteral tube feeding. Among non-ACAP patients, 1,709 (70.8%) had CAP/AspRF+ and 704 (29.2%) had CAP/AspRF-. Microbiology patterns including anaerobes were similar between CAP/AspRF-, CAP/AspRF+ and ACAP (0.0% vs 1.03% vs 1.64%). Patients with severe ACAP had higher rates of total gram-negative bacteria (64.3% vs 44.3% vs 33.3%, P = .021) and lower rates of total gram-positive bacteria (7.1% vs 38.1% vs 50.0%, P < .001) when compared with patients with severe CAP/AspRF+ and severe CAP/AspRF-, respectively. Most patients (>50% in all groups) independent of AspRFs or ACAP received specific or broad-spectrum anti-anaerobic coverage antibiotics. INTERPRETATION: Hospitalized patients with ACAP or CAP/AspRF+ had similar anaerobic flora compared with patients without aspiration risk factors. Gram-negative bacteria were more prevalent in patients with severe ACAP. Despite having similar microbiological flora between groups, a large proportion of CAP patients received anti-anaerobic antibiotic coverage.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Marin-Corral J, Pascual-Guardia S, Amati F, et al. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2020. PMID: 32687909. doi:10.1016/j.chest.2020.06.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。